Zymeworks, Inc. (ZYME)
28.77
+0.10
(+0.35%)
USD |
NASDAQ |
Aug 24, 16:00
29.00
+0.23
(+0.80%)
After-Hours: 20:00
Zymeworks Market Cap : 2.070B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.070B |
| August 21, 2026 | 2.063B |
| August 20, 2026 | 1.912B |
| August 19, 2026 | 1.958B |
| August 18, 2026 | 1.876B |
| August 17, 2026 | 1.821B |
| August 14, 2026 | 1.808B |
| August 13, 2026 | 1.854B |
| August 12, 2026 | 1.794B |
| August 11, 2026 | 1.750B |
| August 10, 2026 | 1.739B |
| August 07, 2026 | 1.694B |
| August 06, 2026 | 1.664B |
| August 05, 2026 | 1.691B |
| August 04, 2026 | 1.679B |
| August 03, 2026 | 1.606B |
| July 31, 2026 | 1.616B |
| July 30, 2026 | 1.673B |
| July 29, 2026 | 1.621B |
| July 28, 2026 | 1.665B |
| July 27, 2026 | 1.694B |
| July 24, 2026 | 1.684B |
| July 23, 2026 | 1.703B |
| July 22, 2026 | 1.721B |
| July 21, 2026 | 1.771B |
| Date | Value |
|---|---|
| July 20, 2026 | 1.750B |
| July 17, 2026 | 1.782B |
| July 16, 2026 | 1.782B |
| July 15, 2026 | 1.816B |
| July 14, 2026 | 1.816B |
| July 13, 2026 | 1.837B |
| July 10, 2026 | 1.906B |
| July 09, 2026 | 1.994B |
| July 08, 2026 | 1.963B |
| July 07, 2026 | 1.968B |
| July 06, 2026 | 1.866B |
| July 02, 2026 | 1.938B |
| July 01, 2026 | 1.894B |
| June 30, 2026 | 1.925B |
| June 29, 2026 | 1.775B |
| June 26, 2026 | 1.779B |
| June 25, 2026 | 1.751B |
| June 24, 2026 | 1.790B |
| June 23, 2026 | 1.759B |
| June 22, 2026 | 1.713B |
| June 18, 2026 | 1.704B |
| June 17, 2026 | 1.704B |
| June 16, 2026 | 1.656B |
| June 15, 2026 | 1.713B |
| June 12, 2026 | 1.685B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Theravance Biopharma, Inc. | 882.67M |
| BridgeBio Pharma, Inc. | 15.83B |
| Aprea Therapeutics, Inc. | 9.977M |
| ACADIA Pharmaceuticals, Inc. | 5.104B |
| Alnylam Pharmaceuticals, Inc. | 31.56B |
Market Cap Related Metrics
| PS Ratio | 57.88 |
| PEG Ratio | -0.1354 |
| Price to Book Value | 25.76 |
| Price | 28.77 |
| Earnings Yield | -7.00% |
| PEGY Ratio | -0.1354 |